2019-03-21 08:00
CEO’s comments Continued focus on commercialization of DiviTum® The focus of Biovica’s business plan is commercialization of DiviTum®, which will provide cancer patients with more personalized treatments leading to better outcomes...
>4,500
Numbers of patients in studies
28
Publications
19
Pharma Projects